‘Pvt investment in biopharma won’t scale without govt risk-sharing, ‘ says Rajesh Jain
Published on: Dec. 14, 2025, 7:13 p.m. | Source: The Financial Express
Industry leaders suggest consortium models and government assurance to spur funding in biologics, biosimilars, and cell & gene therapies, while leveraging the rupee's depreciation advantage on exports.
